TingZhouMD

PubMed

• 39 citations
  Revisiting the case for genetically engineered mouse models in human myelodysplastic syndrome research
  Ting Zhou, Marsha C. Kinney, Linda M. Scott, Sandra S. Zinkel, Vivienne I. Rebel> ;Blood. 2015 Aug 27
• 180 citations
  Dnmt3a loss predisposes murine hematopoietic stem cells to malignant transformation
  Allison Mayle, Liubin Yang, Benjamin Rodriguez, Ting Zhou, Edmund C. Chang, Choladda V. Curry, Grant A. Challen, Wei Li, David A. Wheeler, Vivienne I. Rebel, Margaret ...> ;Blood. 2015 Jan 22
• 32 citations
  Myelodysplastic syndrome: An inability to appropriately respond to damaged DNA?
  Ting Zhou, Paul Hasty, Christi A. Walter, Alexander J.R. Bishop, Linda M. Scott, Vivienne I. Rebel> ;Experimental Hematology. 2013 Aug 1
• 11 citations
  Dominant-negative C/ebpα and polycomb group protein Bmi1 extend short-lived hematopoietic stem/progenitor cell life span and induce lethal dyserythropoiesis.
  Ting Zhou, Lei Wang, Kang-Yong Zhu, Mei Dong, Peng-Fei Xu, Yi Chen, Sai-Juan Chen, Zhu Chen, Min Deng, Ting Xi Liu> ;Blood. 2011 Oct 6
• 42 citations
  Crebbp haploinsufficiency in mice alters the bone marrow microenvironment, leading to loss of stem cells and excessive myelopoiesis.
  Stephanie N. Zimmer, Qing Zhou, Ting Zhou, Ziming Cheng, Sherry L. Abboud-Werner, Diane Horn, Michael Lecocke, Ruth White, Andrei V. Krivtsov, Scott A. Armstrong, Andr...> ;Blood. 2011 Jul 7
• Potential relationship between inadequate response to DNA damage and development of myelodysplastic syndrome.
  Zhou, T.,Chen, P.,Gu, J.,Bishop, A. J.,Scott, L. M.,Hasty, P.,Rebel, V. I.> ;Int J Mol Sci. 2015 Jan 09
• Join now to see all